Medicare Enrolled
Dr. Gene Finley, MD
Hematology & Oncology · Natrona Heights, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Finley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Finley?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Finley
Dr. Gene Finley is a hematology & oncology specialist in Natrona Heights, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Finley performed 615 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Finley received a total of $84,500 from 68 pharmaceutical and/or device companies across 530 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Finley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ 615 Medicare services
$84,500 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗615
Medicare services
Bottom 49% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
379 | $70 | $286 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
88 | $106 | $423 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $48 | $194 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
34 | $94 | $331 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
30 | $62 | $227 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
27 | $136 | $524 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$84,500
Total received (2018-2024)
Avg $12,071/year across 7 years
Top 6% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
530
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,878
2023
$5,899
2022
$13,666
2021
$19,072
2020
$3,549
2019
$11,946
2018
$26,490
Payments by company (2024)
Astellas Pharma US Inc
$295
Daiichi Sankyo Inc.
$286
Regeneron Healthcare Solutions, Inc.
$278
Novartis Pharmaceuticals Corporation
$228
PFIZER INC.
$225
Acrotech Biopharma Inc.
$203
Janssen Biotech, Inc.
$199
E.R. Squibb & Sons, L.L.C.
$177
Genentech USA, Inc.
$143
AstraZeneca Pharmaceuticals LP
$136
Iovance Biotherapeutics, Inc.
$121
Bayer Healthcare Pharmaceuticals Inc.
$117
Merck Sharp & Dohme LLC
$116
Aveo Pharmaceuticals, Inc.
$108
Rigel Pharmaceuticals, Inc.
$100
GlaxoSmithKline, LLC.
$99
Eisai Inc.
$97
Incyte Corporation
$86
Lilly USA, LLC
$70
Celgene Corporation
$63
Genmab U.S., Inc.
$57
ADC Therapeutics America, Inc.
$55
SOBI, INC
$48
GENZYME CORPORATION
$47
BeiGene USA, Inc.
$46
ARRAY BIOPHARMA INC
$46
Exelixis Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$44
Gilead Sciences, Inc.
$39
PharmaEssentia USA Corporation
$37
Karyopharm Therapeutics Inc.
$34
ABBVIE INC.
$32
Ipsen Biopharmaceuticals, Inc
$31
Sumitomo Pharma America, Inc.
$28
Deciphera Pharmaceuticals Inc.
$26
Janssen Pharmaceuticals, Inc
$25
Alexion Pharmaceuticals, Inc.
$20
Kite Pharma, Inc.
$20
TerSera Therapeutics LLC
$18
Kyowa Kirin, Inc.
$18
TAIHO ONCOLOGY, INC.
$18
Top 3 companies account for 22.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$27,049
F. Hoffmann-La Roche AG
$22,449
E.R. Squibb & Sons, L.L.C.
$19,745
Genentech USA, Inc.
$4,656
Secura Bio, Inc.
$1,598
Bayer HealthCare Pharmaceuticals Inc.
$950
Merck Sharp & Dohme Corporation
$724
Novartis Pharmaceuticals Corporation
$608
Astellas Pharma US Inc
$533
PFIZER INC.
$389
Daiichi Sankyo Inc.
$374
Janssen Biotech, Inc.
$354
Regeneron Healthcare Solutions, Inc.
$312
Lilly USA, LLC
$300
Incyte Corporation
$293
Acrotech Biopharma Inc.
$240
Celgene Corporation
$234
Ipsen Biopharmaceuticals, Inc
$224
Gilead Sciences, Inc.
$196
GENZYME CORPORATION
$191
Bayer Healthcare Pharmaceuticals Inc.
$169
Merck Sharp & Dohme LLC
$161
Novocure Inc.
$129
Rigel Pharmaceuticals, Inc.
$122
Iovance Biotherapeutics, Inc.
$121
Eisai Inc.
$116
Amgen Inc.
$113
SOBI, INC
$110
Aveo Pharmaceuticals, Inc.
$108
Seagen Inc.
$105
Kite Pharma, Inc.
$104
GlaxoSmithKline, LLC.
$99
BeiGene USA, Inc.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$95
Foundation Medicine, Inc.
$94
Exelixis Inc.
$92
Genmab U.S., Inc.
$92
Sumitomo Pharma America, Inc.
$80
ADC Therapeutics America, Inc.
$73
Janssen Scientific Affairs, LLC
$73
ARRAY BIOPHARMA INC
$69
Alexion Pharmaceuticals, Inc.
$68
TerSera Therapeutics LLC
$65
Mirati Therapeutics, Inc.
$58
Blueprint Medicines Corporation
$47
Teva Pharmaceuticals USA, Inc.
$46
Janssen Pharmaceuticals, Inc
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
TAIHO ONCOLOGY, INC.
$39
PharmaEssentia USA Corporation
$37
Karyopharm Therapeutics Inc.
$34
Kyowa Kirin, Inc.
$34
Pharmacyclics LLC, An AbbVie Company
$34
ABBVIE INC.
$32
Dendreon Pharmaceuticals LLC
$29
Ethicon US, LLC
$28
AbbVie, Inc.
$26
Deciphera Pharmaceuticals Inc.
$26
Astellas Pharma Global Development
$25
Stemline Therapeutics Inc.
$20
Covidien LP
$19
Seattle Genetics, Inc.
$19
Myovant Sciences Inc.
$17
Clovis Oncology, Inc.
$16
TESARO, Inc.
$16
Acrotech Biopharma LLC
$12
Puma Biotechnology, Inc.
$11
EMD Serono, Inc.
$11
Top 3 companies account for 81.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · Amtagvi · Avastin · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · Herceptin · IBRANCE · IMFINZI · IMLYGIC · INJECTAFER · INLYTA · Imbruvica · Itovebi · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SURGICEL Family of Absorbable Hemostats · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEVIMBRA · Tazverik · Tecentriq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZOLADEX · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
106
County median income
$76,393
Nearest hospital to ZIP centroid (approximate)
ALLEGHENY VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Finley is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Finley experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Finley performed 379 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Finley receive payments from pharmaceutical companies?
Yes. Dr. Finley received a total of $84,500 from 68 companies across 530 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Finley's costs compare to other hematology & oncology specialists in Natrona Heights?
Dr. Finley's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Finley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Natrona Heights
Browse hematology & oncology specialists in Natrona Heights ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
F. Hoffmann-La Roche AG Payments to Doctors
See all physicians who received payments from F. Hoffmann-La Roche AG.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology